SCHEMBL2964011

SCHEMBL2964011

CCCCc1coc([P])c1CCCC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.38
MAPK1 P28482 2/20 0.38
NPC1 O15118 1/20 0.38
HPGD P15428 1/20 0.38
RAB9A P51151 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TYR P14679 3/20 0.37
MAPT P10636 4/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ALDH1A1 P00352 3/20 0.33
CTRC Q99895 1/20 0.33
KDM4E B2RXH2 2/20 0.33
PKM P14618 1/20 0.33
LIPG Q9Y5X9 1/20 0.32
GAA P10253 2/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
ERAP1 Q9NZ08 1/20 0.31
CYP3A4 P08684 2/20 0.31
THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2958520 0.83 HMGCR (0.31)
SCHEMBL25632014 0.79 MAPT (0.36) HTTMAPK1NPC1HPGDRAB9A
SCHEMBL6785369 0.78 MAPT (0.36) HTTMAPK1NPC1HPGDRAB9A
SCHEMBL2969617 0.76 MAPT (0.35) HTTMAPK1NPC1HPGDRAB9A
SCHEMBL11781337 0.76 TYR (0.36) HTTMAPK1NPC1HPGDRAB9A
SCHEMBL19520719 0.71 TYR (0.40) HTTTYRMAPTALDH1A1KDM4E
SCHEMBL2973154 0.69 TYR (0.41) HTTHPGDTYRMAPTSMN1; SMN2
SCHEMBL28292554 0.69 GABRP (0.38) HPGDMAPTALDH1A1CTRCKDM4E
SCHEMBL2303596 0.68 CYP3A4 (0.32) MAPK1TYRMAPTSMN1; SMN2ALDH1A1
SCHEMBL2972410 0.68 HTT (0.38) HTTMAPK1NPC1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed
US-7214746-B2 Phosphorus bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-05-08 US disclosed
US-20050239981-A1 Phosphorus bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2005-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239981-A1 Phosphorus bridged metallocene compounds for olefin polymerization PYM1, ZNF207, POLL HTT 4838/4885MAPK1 2369/4885NPC1 4195/4885
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 HTT 3857/4885MAPK1 3118/4885NPC1 4083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.